Jan 18, 2026
What randomized evidence exists on cardiovascular outcomes after planned discontinuation of GLP‑1 therapy?
Randomized trial data directly assessing cardiovascular outcomes after a planned, protocolized discontinuation of GLP‑1 receptor agonists are scarce: most randomized controlled trials (RCTs) report ca...